Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6XDM
|
||||
| Drug Name |
(2R,3S)-2-Cyclopentyl-N*4*-((S)-2,2-dimethyl-1-methylcarbamoyl-propyl)-N*1*-hydroxy-3-isobutyl-succinamide
|
||||
| Synonyms |
CHEMBL29976
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H37N3O4
|
||||
| Canonical SMILES |
CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](C1CCCC1)C(=O)NO)C(C)(C)C
|
||||
| InChI |
InChI=1S/C20H37N3O4/c1-12(2)11-14(15(18(25)23-27)13-9-7-8-10-13)17(24)22-16(19(26)21-6)20(3,4)5/h12-16,27H,7-11H2,1-6H3,(H,21,26)(H,22,24)(H,23,25)/t14-,15+,16-/m1/s1
|
||||
| InChIKey |
QXLMMZHXXOWCDY-OWCLPIDISA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Interstitial collagenase | Target Info | [1587926] | ||
| Neutrophil collagenase | Target Info | [1587926] | |||
| WikiPathways | TGF beta Signaling Pathway | ||||
| Bladder Cancer | |||||
| Activation of Matrix Metalloproteinases | |||||
| Degradation of collagen | |||||
| Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | |||||
| Oncostatin M Signaling Pathway | |||||
| Prostate Cancer | |||||
| Integrated Breast Cancer Pathway | |||||
| Integrated Cancer pathway | |||||
| Cell surface interactions at the vascular wall | |||||
| Matrix MetalloproteinasesWP2769:Activation of Matrix Metalloproteinases | |||||
| Matrix Metalloproteinases | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.